VPM-1002 is under clinical development by Serum Institute of India and currently in Phase II for Transitional Cell Carcinoma (Urothelial Cell Carcinoma). According to GlobalData, Phase II drugs for ...

Citation: SGLT2 inhibitor empagliflozin is shown to be safe and effective for treating patients who have suffered a heart attack (2024, September 2) retrieved 20 September 2024 from https ...

We show that this workflow can indeed recognize bioactive compounds in these microbial fractions. In addition, the specific inhibition of enteropathogenic Escherichia coli (EPEC) virulence could offer ...

Olay Super Serum is a face serum that targets five different skin issues, all in one product. Gone are the days of a lineup of serums that each cater to a different concern. This formula makes it ...

Zasocitinib, a tyrosine kinase 2 (TYK2) inhibitor, at oral doses of ≥ 5 mg led to greater skin clearance than placebo over a period of 12 weeks, in a phase 2b study. Researchers performed a ...